nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—primary biliary cirrhosis—systemic lupus erythematosus	0.686	1	CtDrD
Chenodeoxycholic acid—UGT2B7—Mycophenolate mofetil—systemic lupus erythematosus	0.0852	0.519	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0115	0.0703	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Dapsone—systemic lupus erythematosus	0.0101	0.0614	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00875	0.0533	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00875	0.0533	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00751	0.0457	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00741	0.0451	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00702	0.0427	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Prednisone—systemic lupus erythematosus	0.007	0.0426	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00663	0.0404	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00437	0.0266	CbGbCtD
Chenodeoxycholic acid—NR1H4—connective tissue—systemic lupus erythematosus	0.00191	0.0902	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Vitamin D Metabolism—RXRA—systemic lupus erythematosus	0.00187	0.069	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—nephron tubule—systemic lupus erythematosus	0.00185	0.0874	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Vitamin D Metabolism—VDR—systemic lupus erythematosus	0.00169	0.0625	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—kidney—systemic lupus erythematosus	0.00162	0.0768	CbGeAlD
Chenodeoxycholic acid—NR1H4—cortex of kidney—systemic lupus erythematosus	0.00158	0.0748	CbGeAlD
Chenodeoxycholic acid—CYP27A1—connective tissue—systemic lupus erythematosus	0.00139	0.0657	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—RXRA—systemic lupus erythematosus	0.00135	0.0499	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—nephron tubule—systemic lupus erythematosus	0.00134	0.0636	CbGeAlD
Chenodeoxycholic acid—CYP27A1—skin of body—systemic lupus erythematosus	0.00125	0.0593	CbGeAlD
Chenodeoxycholic acid—CYP3A4—urine—systemic lupus erythematosus	0.00121	0.057	CbGeAlD
Chenodeoxycholic acid—CYP27A1—kidney—systemic lupus erythematosus	0.00118	0.0559	CbGeAlD
Chenodeoxycholic acid—CYP27A1—cortex of kidney—systemic lupus erythematosus	0.00115	0.0544	CbGeAlD
Chenodeoxycholic acid—UGT2B7—kidney—systemic lupus erythematosus	0.00105	0.0495	CbGeAlD
Chenodeoxycholic acid—CYP27A1—lymphoid tissue—systemic lupus erythematosus	0.00102	0.048	CbGeAlD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—RXRA—systemic lupus erythematosus	0.000986	0.0365	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Endogenous sterols—RXRA—systemic lupus erythematosus	0.000959	0.0355	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—tendon—systemic lupus erythematosus	0.000954	0.0451	CbGeAlD
Chenodeoxycholic acid—NR1H4—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000937	0.0346	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—RXRA—systemic lupus erythematosus	0.000927	0.0343	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Synthesis of bile acids and bile salts—RXRA—systemic lupus erythematosus	0.000843	0.0312	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—lung—systemic lupus erythematosus	0.000837	0.0396	CbGeAlD
Chenodeoxycholic acid—NR1H4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000816	0.0302	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000808	0.0299	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—nervous system—systemic lupus erythematosus	0.000776	0.0367	CbGeAlD
Chenodeoxycholic acid—CYP27A1—central nervous system—systemic lupus erythematosus	0.000747	0.0353	CbGeAlD
Chenodeoxycholic acid—NR1H4—Endogenous sterols—RXRA—systemic lupus erythematosus	0.000701	0.0259	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—RXRA—systemic lupus erythematosus	0.000677	0.025	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.00067	0.0248	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.000635	0.0235	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—blood plasma—systemic lupus erythematosus	0.000629	0.0298	CbGeAlD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts—RXRA—systemic lupus erythematosus	0.000616	0.0228	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000575	0.0213	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000532	0.0197	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.00049	0.0181	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000464	0.0172	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000445	0.0165	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—PPARG—systemic lupus erythematosus	0.000401	0.0148	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.00038	0.0141	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.00037	0.0137	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000361	0.0133	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—NAT2—systemic lupus erythematosus	0.000342	0.0126	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000337	0.0125	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000336	0.0124	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000325	0.012	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000324	0.012	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000302	0.0112	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—kidney—systemic lupus erythematosus	0.000285	0.0135	CbGeAlD
Chenodeoxycholic acid—NR1H4—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000278	0.0103	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—NAT2—systemic lupus erythematosus	0.000266	0.00985	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000264	0.00975	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—NAT2—systemic lupus erythematosus	0.00025	0.00924	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000234	0.00865	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000228	0.00843	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000213	0.00788	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Orphan transporters—RXRA—systemic lupus erythematosus	0.00021	0.00775	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000201	0.00743	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—RXRA—systemic lupus erythematosus	0.0002	0.00741	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	0.000196	0.00725	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000195	0.00722	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—RXRA—systemic lupus erythematosus	0.000192	0.00709	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—nervous system—systemic lupus erythematosus	0.000187	0.00885	CbGeAlD
Chenodeoxycholic acid—CYP3A4—central nervous system—systemic lupus erythematosus	0.00018	0.00852	CbGeAlD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—NAT2—systemic lupus erythematosus	0.000156	0.00576	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000154	0.00568	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—RXRA—systemic lupus erythematosus	0.00014	0.00518	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	0.000135	0.005	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—PPARG—systemic lupus erythematosus	0.000126	0.00468	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	0.000124	0.00458	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000117	0.00432	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000116	0.00428	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000106	0.00391	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—RXRA—systemic lupus erythematosus	9.95e-05	0.00368	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MTA2—systemic lupus erythematosus	9.57e-05	0.00354	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—RXRA—systemic lupus erythematosus	8.73e-05	0.00323	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	8.53e-05	0.00315	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—EP300—systemic lupus erythematosus	8.27e-05	0.00306	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	8.1e-05	0.003	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	7.7e-05	0.00285	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.36e-05	0.00272	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	7.3e-05	0.0027	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	6.64e-05	0.00246	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—TNFSF13—systemic lupus erythematosus	6.46e-05	0.00239	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	6.4e-05	0.00237	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SNRPB—systemic lupus erythematosus	6.26e-05	0.00232	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NAT2—systemic lupus erythematosus	5.85e-05	0.00216	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—VDR—systemic lupus erythematosus	5.8e-05	0.00214	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	5.58e-05	0.00206	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.38e-05	0.00199	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	5.22e-05	0.00193	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.12e-05	0.00189	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—HIST2H2AC—systemic lupus erythematosus	5.03e-05	0.00186	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4.66e-05	0.00172	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.65e-05	0.00172	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	4.63e-05	0.00171	CbGpPWpGaD
Chenodeoxycholic acid—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.54e-05	0.00045	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.54e-05	0.00045	CcSEcCtD
Chenodeoxycholic acid—Nausea—Leflunomide—systemic lupus erythematosus	4.53e-05	0.000449	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	4.52e-05	0.000448	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.51e-05	0.000447	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.51e-05	0.000447	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.49e-05	0.000445	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.49e-05	0.000445	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.48e-05	0.000444	CcSEcCtD
Chenodeoxycholic acid—Pain—Hydrocortisone—systemic lupus erythematosus	4.47e-05	0.000443	CcSEcCtD
Chenodeoxycholic acid—Oedema—Betamethasone—systemic lupus erythematosus	4.47e-05	0.000443	CcSEcCtD
Chenodeoxycholic acid—Oedema—Dexamethasone—systemic lupus erythematosus	4.47e-05	0.000443	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Triamcinolone—systemic lupus erythematosus	4.45e-05	0.000441	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.44e-05	0.00044	CcSEcCtD
Chenodeoxycholic acid—Infection—Betamethasone—systemic lupus erythematosus	4.44e-05	0.00044	CcSEcCtD
Chenodeoxycholic acid—Infection—Dexamethasone—systemic lupus erythematosus	4.44e-05	0.00044	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.42e-05	0.000438	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.42e-05	0.000438	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.41e-05	0.000437	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.41e-05	0.000437	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Methotrexate—systemic lupus erythematosus	4.41e-05	0.000437	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Prednisone—systemic lupus erythematosus	4.41e-05	0.000437	CcSEcCtD
Chenodeoxycholic acid—Shock—Betamethasone—systemic lupus erythematosus	4.4e-05	0.000436	CcSEcCtD
Chenodeoxycholic acid—Shock—Dexamethasone—systemic lupus erythematosus	4.4e-05	0.000436	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.39e-05	0.000435	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.38e-05	0.000434	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.38e-05	0.000434	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.37e-05	0.000434	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.37e-05	0.000434	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Dexamethasone—systemic lupus erythematosus	4.36e-05	0.000432	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Betamethasone—systemic lupus erythematosus	4.36e-05	0.000432	CcSEcCtD
Chenodeoxycholic acid—Angioedema—Prednisone—systemic lupus erythematosus	4.36e-05	0.000432	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.34e-05	0.00043	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.33e-05	0.00043	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.32e-05	0.000429	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.32e-05	0.000428	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.32e-05	0.000428	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.31e-05	0.000427	CcSEcCtD
Chenodeoxycholic acid—Malaise—Prednisone—systemic lupus erythematosus	4.3e-05	0.000426	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Prednisone—systemic lupus erythematosus	4.28e-05	0.000425	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Methotrexate—systemic lupus erythematosus	4.28e-05	0.000424	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.28e-05	0.000424	CcSEcCtD
Chenodeoxycholic acid—Syncope—Prednisone—systemic lupus erythematosus	4.28e-05	0.000424	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—NAT2—systemic lupus erythematosus	4.27e-05	0.00158	CbGpPWpGaD
Chenodeoxycholic acid—Tinnitus—Methotrexate—systemic lupus erythematosus	4.27e-05	0.000423	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Dexamethasone—systemic lupus erythematosus	4.26e-05	0.000422	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Betamethasone—systemic lupus erythematosus	4.26e-05	0.000422	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Prednisolone—systemic lupus erythematosus	4.25e-05	0.000422	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.25e-05	0.000421	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Triamcinolone—systemic lupus erythematosus	4.25e-05	0.000421	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.24e-05	0.00042	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.23e-05	0.000419	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Cyclosporine—systemic lupus erythematosus	4.22e-05	0.000418	CcSEcCtD
Chenodeoxycholic acid—Pain—Triamcinolone—systemic lupus erythematosus	4.21e-05	0.000417	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.19e-05	0.000415	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.18e-05	0.00155	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Dexamethasone—systemic lupus erythematosus	4.18e-05	0.000414	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Betamethasone—systemic lupus erythematosus	4.18e-05	0.000414	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Cyclosporine—systemic lupus erythematosus	4.16e-05	0.000413	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Hydrocortisone—systemic lupus erythematosus	4.15e-05	0.000412	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Methotrexate—systemic lupus erythematosus	4.15e-05	0.000412	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.13e-05	0.00041	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.13e-05	0.00041	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.13e-05	0.00041	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Prednisone—systemic lupus erythematosus	4.13e-05	0.000409	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.13e-05	0.000409	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.12e-05	0.000408	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Prednisone—systemic lupus erythematosus	4.12e-05	0.000408	CcSEcCtD
Chenodeoxycholic acid—Chills—Methotrexate—systemic lupus erythematosus	4.11e-05	0.000407	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.07e-05	0.000403	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.07e-05	0.000403	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.06e-05	0.000402	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Prednisone—systemic lupus erythematosus	4.06e-05	0.000402	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Prednisone—systemic lupus erythematosus	4.06e-05	0.000402	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.06e-05	0.000402	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.05e-05	0.000401	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Methotrexate—systemic lupus erythematosus	4.04e-05	0.000401	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Dexamethasone—systemic lupus erythematosus	4.04e-05	0.0004	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Betamethasone—systemic lupus erythematosus	4.04e-05	0.0004	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	4.04e-05	0.00149	CbGpPWpGaD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.03e-05	0.000399	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.03e-05	0.000399	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.02e-05	0.000398	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.01e-05	0.000398	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.01e-05	0.000398	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Prednisone—systemic lupus erythematosus	4.01e-05	0.000397	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000395	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.95e-05	0.000391	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.93e-05	0.00039	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.93e-05	0.00039	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.93e-05	0.000389	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Triamcinolone—systemic lupus erythematosus	3.91e-05	0.000388	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.9e-05	0.000387	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.89e-05	0.000386	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Cyclosporine—systemic lupus erythematosus	3.89e-05	0.000386	CcSEcCtD
Chenodeoxycholic acid—Oedema—Prednisone—systemic lupus erythematosus	3.89e-05	0.000386	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.88e-05	0.000385	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.88e-05	0.000385	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.88e-05	0.000385	CcSEcCtD
Chenodeoxycholic acid—Infection—Prednisone—systemic lupus erythematosus	3.87e-05	0.000383	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.86e-05	0.000382	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.86e-05	0.000382	CcSEcCtD
Chenodeoxycholic acid—Back pain—Methotrexate—systemic lupus erythematosus	3.85e-05	0.000382	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.85e-05	0.000382	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Dexamethasone—systemic lupus erythematosus	3.85e-05	0.000382	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Betamethasone—systemic lupus erythematosus	3.85e-05	0.000382	CcSEcCtD
Chenodeoxycholic acid—Shock—Prednisone—systemic lupus erythematosus	3.83e-05	0.000379	CcSEcCtD
Chenodeoxycholic acid—Pain—Betamethasone—systemic lupus erythematosus	3.82e-05	0.000379	CcSEcCtD
Chenodeoxycholic acid—Pain—Dexamethasone—systemic lupus erythematosus	3.82e-05	0.000379	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.82e-05	0.000378	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Prednisone—systemic lupus erythematosus	3.8e-05	0.000376	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.8e-05	0.000376	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Prednisone—systemic lupus erythematosus	3.78e-05	0.000375	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.77e-05	0.0014	CbGpPWpGaD
Chenodeoxycholic acid—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.76e-05	0.000373	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.75e-05	0.000372	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Cyclosporine—systemic lupus erythematosus	3.74e-05	0.000371	CcSEcCtD
Chenodeoxycholic acid—Rash—Cyclosporine—systemic lupus erythematosus	3.71e-05	0.000368	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Prednisone—systemic lupus erythematosus	3.71e-05	0.000368	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.71e-05	0.000367	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.7e-05	0.000367	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.7e-05	0.000366	CcSEcCtD
Chenodeoxycholic acid—Headache—Cyclosporine—systemic lupus erythematosus	3.69e-05	0.000365	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Methotrexate—systemic lupus erythematosus	3.68e-05	0.000365	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.68e-05	0.000365	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.68e-05	0.000365	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.66e-05	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.65e-05	0.000362	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.65e-05	0.000362	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.65e-05	0.000362	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.63e-05	0.00036	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.62e-05	0.000359	CcSEcCtD
Chenodeoxycholic acid—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.62e-05	0.000359	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.62e-05	0.000358	CcSEcCtD
Chenodeoxycholic acid—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.6e-05	0.000356	CcSEcCtD
Chenodeoxycholic acid—Malaise—Methotrexate—systemic lupus erythematosus	3.59e-05	0.000356	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Methotrexate—systemic lupus erythematosus	3.58e-05	0.000355	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.58e-05	0.000355	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	3.58e-05	0.00132	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—TGFB1—systemic lupus erythematosus	3.57e-05	0.00132	CbGpPWpGaD
Chenodeoxycholic acid—Leukopenia—Methotrexate—systemic lupus erythematosus	3.57e-05	0.000353	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Dexamethasone—systemic lupus erythematosus	3.55e-05	0.000352	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Betamethasone—systemic lupus erythematosus	3.55e-05	0.000352	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.55e-05	0.000351	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Prednisolone—systemic lupus erythematosus	3.54e-05	0.000351	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Triamcinolone—systemic lupus erythematosus	3.53e-05	0.00035	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.53e-05	0.00035	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.53e-05	0.00035	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.53e-05	0.00035	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.53e-05	0.00035	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.53e-05	0.0013	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.53e-05	0.000349	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Prednisone—systemic lupus erythematosus	3.52e-05	0.000349	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—JUNB—systemic lupus erythematosus	3.52e-05	0.0013	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Cyclosporine—systemic lupus erythematosus	3.5e-05	0.000346	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Prednisone—systemic lupus erythematosus	3.49e-05	0.000346	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Triamcinolone—systemic lupus erythematosus	3.48e-05	0.000345	CcSEcCtD
Chenodeoxycholic acid—Cough—Methotrexate—systemic lupus erythematosus	3.48e-05	0.000345	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.48e-05	0.000345	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.46e-05	0.000343	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000342	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Prednisone—systemic lupus erythematosus	3.43e-05	0.000339	CcSEcCtD
Chenodeoxycholic acid—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.41e-05	0.000338	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.4e-05	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—Arthralgia—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000336	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000336	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000336	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Prednisone—systemic lupus erythematosus	3.38e-05	0.000335	CcSEcCtD
Chenodeoxycholic acid—Rash—Prednisolone—systemic lupus erythematosus	3.38e-05	0.000335	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Prednisolone—systemic lupus erythematosus	3.37e-05	0.000334	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.37e-05	0.000334	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.36e-05	0.000333	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Prednisone—systemic lupus erythematosus	3.35e-05	0.000332	CcSEcCtD
Chenodeoxycholic acid—Headache—Prednisolone—systemic lupus erythematosus	3.35e-05	0.000332	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Methotrexate—systemic lupus erythematosus	3.35e-05	0.000332	CcSEcCtD
Chenodeoxycholic acid—Constipation—Prednisone—systemic lupus erythematosus	3.33e-05	0.00033	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.33e-05	0.00033	CcSEcCtD
Chenodeoxycholic acid—Rash—Hydrocortisone—systemic lupus erythematosus	3.3e-05	0.000327	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.29e-05	0.000326	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Methotrexate—systemic lupus erythematosus	3.28e-05	0.000325	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—RXRA—systemic lupus erythematosus	3.28e-05	0.00121	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Hydrocortisone—systemic lupus erythematosus	3.28e-05	0.000325	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Triamcinolone—systemic lupus erythematosus	3.26e-05	0.000323	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.25e-05	0.000322	CcSEcCtD
Chenodeoxycholic acid—Infection—Methotrexate—systemic lupus erythematosus	3.23e-05	0.00032	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.21e-05	0.000318	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Dexamethasone—systemic lupus erythematosus	3.21e-05	0.000318	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Betamethasone—systemic lupus erythematosus	3.21e-05	0.000318	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.19e-05	0.000316	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.18e-05	0.000316	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.18e-05	0.000315	CcSEcCtD
Chenodeoxycholic acid—Nausea—Prednisolone—systemic lupus erythematosus	3.18e-05	0.000315	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Dexamethasone—systemic lupus erythematosus	3.16e-05	0.000313	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Betamethasone—systemic lupus erythematosus	3.16e-05	0.000313	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000313	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.14e-05	0.000312	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Triamcinolone—systemic lupus erythematosus	3.13e-05	0.00031	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.12e-05	0.00031	CcSEcCtD
Chenodeoxycholic acid—Nausea—Hydrocortisone—systemic lupus erythematosus	3.11e-05	0.000308	CcSEcCtD
Chenodeoxycholic acid—Rash—Triamcinolone—systemic lupus erythematosus	3.1e-05	0.000308	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.1e-05	0.000307	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Methotrexate—systemic lupus erythematosus	3.1e-05	0.000307	CcSEcCtD
Chenodeoxycholic acid—Rash—Methylprednisolone—systemic lupus erythematosus	3.1e-05	0.000307	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.1e-05	0.000307	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Prednisone—systemic lupus erythematosus	3.09e-05	0.000306	CcSEcCtD
Chenodeoxycholic acid—Headache—Triamcinolone—systemic lupus erythematosus	3.08e-05	0.000306	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—RXRA—systemic lupus erythematosus	3.08e-05	0.00114	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Methylprednisolone—systemic lupus erythematosus	3.08e-05	0.000305	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Prednisone—systemic lupus erythematosus	3.08e-05	0.000305	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Prednisone—systemic lupus erythematosus	3.08e-05	0.000305	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.06e-05	0.000303	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.06e-05	0.000303	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.05e-05	0.00113	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.04e-05	0.00112	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Methotrexate—systemic lupus erythematosus	3.04e-05	0.000301	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.96e-05	0.000294	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Betamethasone—systemic lupus erythematosus	2.95e-05	0.000293	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Dexamethasone—systemic lupus erythematosus	2.95e-05	0.000293	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000291	CcSEcCtD
Chenodeoxycholic acid—Nausea—Triamcinolone—systemic lupus erythematosus	2.92e-05	0.00029	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Methotrexate—systemic lupus erythematosus	2.92e-05	0.000289	CcSEcCtD
Chenodeoxycholic acid—Nausea—Methylprednisolone—systemic lupus erythematosus	2.92e-05	0.000289	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.9e-05	0.00107	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000287	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Methotrexate—systemic lupus erythematosus	2.89e-05	0.000287	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.87e-05	0.000284	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.86e-05	0.000284	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Dexamethasone—systemic lupus erythematosus	2.84e-05	0.000282	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Betamethasone—systemic lupus erythematosus	2.84e-05	0.000282	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.83e-05	0.00028	CcSEcCtD
Chenodeoxycholic acid—Rash—Betamethasone—systemic lupus erythematosus	2.82e-05	0.000279	CcSEcCtD
Chenodeoxycholic acid—Rash—Dexamethasone—systemic lupus erythematosus	2.82e-05	0.000279	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.81e-05	0.000279	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Betamethasone—systemic lupus erythematosus	2.81e-05	0.000279	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000278	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Methotrexate—systemic lupus erythematosus	2.8e-05	0.000278	CcSEcCtD
Chenodeoxycholic acid—Headache—Betamethasone—systemic lupus erythematosus	2.8e-05	0.000277	CcSEcCtD
Chenodeoxycholic acid—Headache—Dexamethasone—systemic lupus erythematosus	2.8e-05	0.000277	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Prednisone—systemic lupus erythematosus	2.79e-05	0.000277	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—VDR—systemic lupus erythematosus	2.79e-05	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—Pain—Methotrexate—systemic lupus erythematosus	2.78e-05	0.000276	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Prednisone—systemic lupus erythematosus	2.75e-05	0.000273	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.68e-05	0.000266	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.67e-05	0.000988	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NAT2—systemic lupus erythematosus	2.66e-05	0.000985	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Prednisone—systemic lupus erythematosus	2.66e-05	0.000264	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000264	CcSEcCtD
Chenodeoxycholic acid—Nausea—Betamethasone—systemic lupus erythematosus	2.65e-05	0.000263	CcSEcCtD
Chenodeoxycholic acid—Nausea—Dexamethasone—systemic lupus erythematosus	2.65e-05	0.000263	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Methotrexate—systemic lupus erythematosus	2.58e-05	0.000256	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Prednisone—systemic lupus erythematosus	2.57e-05	0.000255	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.57e-05	0.000255	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.57e-05	0.000255	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—NR3C1—systemic lupus erythematosus	2.51e-05	0.000929	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Prednisone—systemic lupus erythematosus	2.47e-05	0.000245	CcSEcCtD
Chenodeoxycholic acid—Rash—Prednisone—systemic lupus erythematosus	2.45e-05	0.000243	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Prednisone—systemic lupus erythematosus	2.45e-05	0.000243	CcSEcCtD
Chenodeoxycholic acid—Headache—Prednisone—systemic lupus erythematosus	2.44e-05	0.000242	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000237	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—RXRA—systemic lupus erythematosus	2.4e-05	0.000886	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Methotrexate—systemic lupus erythematosus	2.33e-05	0.000231	CcSEcCtD
Chenodeoxycholic acid—Nausea—Prednisone—systemic lupus erythematosus	2.31e-05	0.000229	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000228	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000221	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.22e-05	0.000822	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Methotrexate—systemic lupus erythematosus	2.15e-05	0.000213	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPARG—systemic lupus erythematosus	2.07e-05	0.000766	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Methotrexate—systemic lupus erythematosus	2.07e-05	0.000205	CcSEcCtD
Chenodeoxycholic acid—Rash—Methotrexate—systemic lupus erythematosus	2.05e-05	0.000203	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Methotrexate—systemic lupus erythematosus	2.05e-05	0.000203	CcSEcCtD
Chenodeoxycholic acid—Headache—Methotrexate—systemic lupus erythematosus	2.04e-05	0.000202	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	2.01e-05	0.000742	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PPARG—systemic lupus erythematosus	1.95e-05	0.000719	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Methotrexate—systemic lupus erythematosus	1.93e-05	0.000191	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALB—systemic lupus erythematosus	1.86e-05	0.000688	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NOS3—systemic lupus erythematosus	1.78e-05	0.000658	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS2—systemic lupus erythematosus	1.63e-05	0.000602	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PPARG—systemic lupus erythematosus	1.51e-05	0.000559	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—RXRA—systemic lupus erythematosus	1.49e-05	0.000552	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALB—systemic lupus erythematosus	1.36e-05	0.000503	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—EP300—systemic lupus erythematosus	1.35e-05	0.000501	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NOS3—systemic lupus erythematosus	1.3e-05	0.000481	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS2—systemic lupus erythematosus	1.19e-05	0.00044	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—EP300—systemic lupus erythematosus	9.9e-06	0.000366	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPARG—systemic lupus erythematosus	9.43e-06	0.000349	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALB—systemic lupus erythematosus	8.48e-06	0.000314	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NOS3—systemic lupus erythematosus	8.11e-06	0.0003	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS2—systemic lupus erythematosus	7.42e-06	0.000274	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—EP300—systemic lupus erythematosus	6.17e-06	0.000228	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	6.12e-06	0.000226	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	3.43e-06	0.000127	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.17e-06	8.01e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.95e-06	7.2e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.86e-06	6.89e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.7e-06	6.3e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.42e-06	5.24e-05	CbGpPWpGaD
